ACN vs PTCT · P/E 24, rev $17.60B vs rev $633.1M
Accenture plc (ACN) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the ACN and PTCT stock pages for the full models.
Not investment advice.